This website is intended exclusively for healthcare professionals residing and/or working in the UAE.
A clinically significant risk of injury was reported with CENRIFKI (tolebrutinib)¹
Diabetes
Dermatology
Cardiology
Vaccines
Rare Disease
Neurology
Rare Blood Disorders
Respiratory
Hematology
Rhinology
Other topics
Transplant
Gastroenterology